Description
The global market for RNAi technology is estimated to be USD 8.7 billion in 2014 and is expected to reach USD21.9 billion by 2019, growing at a CAGR of 20.19 %
RNA interference( RNAi) is a natural process of treating forms of cancer and other diseases by posttranscriptional silencing of genes by small fragments of the nucleic acid. However, the path of RNAi therapies to the clinic has been more like a roller-coaster ride. RNAi technology can be helpful in providing target specificity to the proteins that lack the enzymatic pocket necessary for binding. Global RNAi Technology Market-Market Dynamics
Request a sample of this report @ http:// www. orbisresearch. com / contacts / request-sample / 219740.
The major drivers for the growth of the market are improving synthetic delivery carriers and chemical modifications to RNA, increasing genetic and metabolic disorders including diseases like cancer and increasing applications in molecular diagnostics, particularly that of cancer. However, the market is facing major challenges because of strict FDA regulations and the fact that RNA is potentially immunogenic and inherently unstable, which causes major problems for the research and development of drugs. Greatly expanding the number of druggable disease targets and potentially streamlining drug development are the market growth opportunities in the coming years.
RNAi technology is showing promise in the treatment of viral infections like hepatitis B virus( HBV), which affects more than 300 million worldwide, killing at least 780,000 annually through liver scarring, liver failure, and liver cancer. There has been a shift in strategic focus of RNAi innovators from RNAi triggers to delivery. Small RNAi therapeutics innovator( pure-play) companies and Big Pharma remain the industry ' s two protagonists, although medium-sized pharmaceutical companies, including those in Asian countries, have taken some of the space vacated by Big Pharma. RNAi technology has application in different sectors like drug discovery and development and therapeutics. Therapeutics is the major growing sector owing to the increased demand for treatment of cancer and liver disorders.
The market is segmented by type of application( drug discovery and development, therapeutics, and others), by therapeutics( oncology, ocular disorders, respiratory disorders, liver diseases, and neuronal disorders) and geography( North America, Europe, and Asia-Pacific).
The key players in the market are focused on the expansion of their business by launching new products and extending the product line. Mergers and acquisitions of small and medium-sized manufacturers to enter the overseas market is another strategy adopted by multinational players. RNAi technologies market is still at their nascent stage but companies are keen on taking this market to a higher level.
Purchase a copy of Global RNAi Technology Market visit @ http:// www. orbisresearch. com / contact / purchase / 219740 For more information contact sales @ orbisresearch. com.
Some of the key players in the market are: Alnylam Pharmaceuticals www. orbisresearch. com; + 1( 214) 884-6817; + 9120-64101019